Drug Type Chemical drugs |
Synonyms CB03-154 |
Target |
Mechanism Kv7.2 modulators(Voltage-gated potassium channel subunit Kv7.2 modulators), Kv7.3 modulators(KCNQ voltage-gated potassium channel-3 modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsy | Phase 1 | US | 02 May 2022 | |
Amyotrophic Lateral Sclerosis | IND Approval | CN | 18 Sep 2024 |